欧洲多国猫杯状病毒流行病学、多样性及疫苗交叉反应性横断面研究
在六个欧洲国家随机选取64家兽医诊所,对就诊猫采集口咽拭子,用病毒分离检测猫杯状病毒(FCV),总体阳性率为9.2%。系统发育分析显示FCV变异广泛且无国别聚集,FCV-F9疫苗株血浆可中和97%的受试分离株,提示抗体对当代分离株仍具广泛交叉反应性。
要点
- 六国64家诊所随机采样,猫FCV总体阳性率为9.2%。
- 多猫家庭、慢性龈口炎、年轻、未绝育及所在国家与FCV排毒正相关。
- FCV-F9血浆中和97%受试分离株,滴度1:4至1:5792。
核心结论
- 体外中和试验结果提示,针对FCV-F9产生的抗体对采样的欧洲国家当代FCV分离株仍保持广泛交叉反应性。
研究设计与样本
- 从英国、瑞典、荷兰、德国、法国和意大利六国随机选取64家兽医诊所,每家诊所请求采集30只(英国)或40只(其他国家)就诊猫的口咽拭子。
- 通过病毒分离确定FCV存在,采用多变量逻辑回归评估FCV排毒的危险因素,用系统发育分析描述FCV种群结构。
- 使用四只已接种疫苗猫的血浆进行体外病毒中和试验,以评估FCV-F9交叉反应性。
主要发现
- FCV总体阳性率为9.2%。
- 与FCV排毒正相关的危险因素包括多猫家庭、慢性龈口炎、年轻、未绝育以及居住在某些国家。
- 系统发育分析显示FCV变异广泛且无全国性聚集,尽管FCV-F9最早于1950年代分离,仍与当代田间分离株聚集在一起。
- 针对FCV-F9产生的血浆中和了97%的受试分离株(滴度1:4至1:5792),分别有26.5%、35.7%和50%的分离株被5、10和20个抗体单位中和。
关键数值与推荐
- FCV总体阳性率为9.2%。
- FCV-F9血浆中和97%的受试分离株,滴度范围为1:4至1:5792。
- 26.5%的分离株被5个抗体单位中和,35.7%被10个抗体单位中和,50%被20个抗体单位中和。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Feline calicivirus (FCV) is an important pathogen of cats for which vaccination is regularly practised. Long-term use of established vaccine antigens raises the theoretical possibility that field viruses could become resistant. This study aimed to assess the current ability of the FCV-F9 vaccine strain to neutralise a randomly collected contemporary panel of FCV field strains collected prospectively in six European countries. METHODS: Veterinary practices (64) were randomly selected from six countries (UK, Sweden, Netherlands, Germany, France and Italy). Oropharyngeal swabs were requested from 30 (UK) and 40 (other countries) cats attending each practice. Presence of FCV was determined by virus isolation, and risk factors for FCV shedding assessed by multivariable logistic regression. Phylogenetic analyses were used to describe the FCV population structure. In vitro virus neutralisation assays were performed to evaluate FCV-F9 cross-reactivity using plasma from four vaccinated cats. RESULTS: The overall prevalence of FCV was 9.2%. Risk factors positively associated with FCV shedding included multi-cat households, chronic gingivostomatitis, younger age, not being neutered, as well as residing in certain countries. Phylogenetic analysis showed extensive variability and no countrywide clusters. Despite being first isolated in the 1950s, FCV-F9 clustered with contemporary field isolates. Plasma raised to FCV-F9 neutralized 97% of tested isolates (titres 1:4 to 1:5792), with 26.5%, 35.7% and 50% of isolates being neutralized by 5, 10 and 20 antibody units respectively. CONCLUSIONS: This study represents the largest prospective analysis of FCV diversity and antigenic cross-reactivity at a European level. The scale and random nature of sampling used gives confidence that the FCV isolates used are broadly representative of FCVs that cats are exposed to in these countries. The in vitro neutralisation results suggest that antibodies raised to FCV-F9 remain broadly cross-reactive to contemporary FCV isolates across the European countries sampled.
引用
- Afonso MM, Pinchbeck GL, Smith SL, et al. A multi-national European cross-sectional study of feline calicivirus epidemiology, diversity and vaccine cross-reactivity. Vaccine. 2017. PMID: 28389099. doi:10.1016/j.vaccine.2017.03.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。